PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Autor: Margieva, A., Omelyanovsky, V., Avxentyeva, M., Krysanov, I., Zorin, N., Andreyeva, N.
Zdroj: In Value in Health November 2012 15(7):A563-A563
Databáze: ScienceDirect